MICHAELEA BETHGE: Open Payments
NPI 1710523642 · SELINSGROVE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$893 in 51 payments from 14 companies in 2025. Trend: 2023 $754 · 2024 $718 · 2025 $893
Food & beverage: $893
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $220 |
| Lilly USA, LLC | 12 | $207 |
| Novo Nordisk Inc | 6 | $105 |
| Exact Sciences Corporation | 3 | $85 |
| Verona Pharma, Inc. | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 3 | $43 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Amgen Inc. | 2 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: MOUNJARO, VRAYLAR, Ohtuvayre, The Cologuard Plus Collection Kit, Rybelsus, QULIPTA, TRELEGY ELLIPTA, Ozempic.
Industry payments across PA — which companies pay providers there.
